Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $93.3 million.

  • Caribou Biosciences' Shares Outstanding (Diluted Average) rose 3.14% to $93.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.3 million, marking a year-over-year increase of 3.14%. This contributed to the annual value of $90.3 million for FY2024, which is 22.37% up from last year.
  • Latest data reveals that Caribou Biosciences reported Shares Outstanding (Diluted Average) of $93.3 million as of Q3 2025, which was up 0.28% from $93.0 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Shares Outstanding (Diluted Average) ranged from a high of $93.3 million in Q3 2025 and a low of $10.3 million during Q2 2021.
  • For the 3-year period, Caribou Biosciences' Shares Outstanding (Diluted Average) averaged around $83.6 million, with its median value being $90.3 million (2024).
  • Data for Caribou Biosciences' Shares Outstanding (Diluted Average) shows a peak YoY spiked of 492.08% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Caribou Biosciences' Shares Outstanding (Diluted Average) stood at $31.7 million in 2021, then soared by 92.02% to $60.8 million in 2022, then grew by 21.39% to $73.8 million in 2023, then increased by 22.37% to $90.3 million in 2024, then increased by 3.14% to $93.3 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $93.3 million for Q3 2025, versus $93.0 million for Q2 2025 and $92.7 million for Q1 2025.